Calidi Biotherapeutics (CLDI) Stock Price
$1.65 3.5%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Calidi Biotherapeutics, AI stock picks, stock alerts and much more.
CLDI AI Stock Analysis
AI stock analysis for CLDI is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Calidi Biotherapeutics (CLDI) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Calidi Biotherapeutics (CLDI) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Calidi Biotherapeutics (CLDI), currently trading at $1.65, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CLDI
-
Calidi Biotherapeutics, Inc.
-
Symbol
CLDI
-
Market
AMEX
-
Industry
Biotechnology
-
Market Cap
4.7M
Similar Stocks
 |
Cybin CYBN |
$7.48 2.1% |
4 |
 |
Lineage Cell Therapeutics LCTX |
$1.17 3.3% |
7 |
 |
NovaBay Pharmaceuticals NBY |
$1.78 7.9% |
4 |
News
CLDI Alternative Data
Web Traffic
Calidi Biotherapeutics receives an estimated 5828 monthly visitors to calidibio.com.
-
Web Traffic
5828
-
Change from Previous Month
75.1%
-
3 Month Change
54.9%
-
YoY Change
54.9%
Twitter Followers
Calidi Biotherapeutics has 187 Twitter Followers on its main Twitter (also known as X) account, which is up by 8.7% over the last month.
-
Twitter Followers
187
-
Daily Change
0%
-
1 Month Change
8.7%
-
3 Month Change
43.8%
-
YoY Change
43.8%
LinkedIn Followers
3,246 are following Calidi Biotherapeutics on LinkedIn, up by 2.6% over the last month.
-
LinkedIn Followers
3246
-
Daily Change
0.1%
-
1 Month Change
2.6%
-
3 Month Change
7.8%
-
YoY Change
7.8%
Job Postings
Calidi Biotherapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Calidi Biotherapeutics has 31 employees.
-
LinkedIn Employees
31
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
3.3%
-
YoY Change
3.3%
Business Outlook
According to employee reviews, the business outlook among employees at Calidi Biotherapeutics is 44 out of 100 (neutral).
-
Business Outlook
44
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Calidi Biotherapeutics has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Calidi Biotherapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
CLDI Financials
CLDI Key Metrics
-
Total Revenue
$0
-
Net Income
-$5.1M
-
Earnings per Share
-$0.65
-
Free cash flow
-$3.8M
-
EBITDA
-$4.4M
-
EBITDA Ratio
0
-
Total Assets
$14.2M
CLDI 2-year Revenue & Income
CLDI 2-year Free Cash Flow
CLDI Technicals
CLDI SMA
CLDI RSI
FAQ
What's the current price of Calidi Biotherapeutics (CLDI) Stock?
The price of an Calidi Biotherapeutics (CLDI) share is $1.65.
What's the market cap of Calidi Biotherapeutics?
The current market cap of Calidi Biotherapeutics is 4.7M.
Should I buy or sell CLDI?
Calidi Biotherapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Calidi Biotherapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Calidi Biotherapeutics a good investment?
The current analysis of Calidi Biotherapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Calidi Biotherapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Calidi Biotherapeutics (CLDI) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Calidi Biotherapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Calidi Biotherapeutics (CLDI) that investors often compare it to?
Calidi Biotherapeutics (CLDI) is often compared to similar stocks such as Cybin, Lineage Cell Therapeutics and NovaBay Pharmaceuticals.
What is the forecast for Calidi Biotherapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Calidi Biotherapeutics' stock price to be around $1.66 in 2026. Starting from the current price of $1.65, this represents a 0.7% change in price, indicating a neutral outlook for the stock.
How to buy Calidi Biotherapeutics (CLDI) Stock?
Calidi Biotherapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Calidi Biotherapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.